« Back to Farmacia Journal 2/2017
THE USE OF ANABOLIC THERAPY IN PATIENTS WITH BETA-THALASSEMIA MAJOR-INDUCED OSTEOPOROSIS – REVIEW OF THE LITERATURE
LUMINIȚA-NICOLETA CIMA1*, SIMONA FICA1,2
1.“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
2.Department of Endocrinology, Diabetes and Metabolic Disorders, Elias Hospital, Bucharest, Romania